EKSO: Ekso Bionics Holdings, Inc. Forward P/S Multiple

Ekso Bionics Holdings Inc. - graphic logo of issuer EKSO

Demand for bionics is rising due to stroke rehabilitation and the reduction of physical strain in manufacturing. The expected P/S dynamics on the general GURU.Markets platform chart show that 3.60 is the current level of the metric for Ekso Bionics Holdings (EKSO). Investors should consider the dependence on government contracts and the high cost of devices, while adhering to basic battery disposal standards and the energy efficiency of assemblies.

EKSO Ekso Bionics Holdings, Inc.: Forward Price-to-Revenue Multiple in the range 07/04/2022 - 05/05/2026

EKSO (Ekso Bionics Holdings, Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Fundamental company analysis:EKSO (Ekso Bionics Holdings, Inc.)
Product sample of Ekso Bionics

The forward P/S reflects the ratio of the current market value of Ekso Bionics Holdings (EKSO) to its expected annual turnover, measuring the price the market is willing to pay per unit of future revenue. By analyzing the forward price-to-sales ratio, an investor assesses the asset's revaluation speed, which is critical for a leader in the exoskeleton market whose technological dominance and medical trust justify a premium share price.